TCP1 and diffuse large B-cell lymphoma: In conclusion, our findings suggest that the molecular heterogeneity of TCP1 expression can be used to discriminate between DLBCL subtypes regarding their prognosis; high TCP1 expression predicts poor prognosis in the non-GCB subtype.